Thursday, August 29, 2019

CRISPR Gene Editing can Stop Progression of Triple-negative Breast Cancer

CRISPR gene editing technique can help stop the progression of triple-negative breast cancer. A new CRISPR nanotherapeutic discovered knocks out a breast cancer oncogene, called Lipocalin 2 (Lcn2) in triple-negative breast cancer.

from Medindia Latest Updates https://ift.tt/2MK0OKq
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

New drugs could wipe out the “zombie cells” linked to cancer and aging

Researchers found a new way to kill harmful “zombie” cells that linger after chemotherapy and help cancers become more aggressive. These sen...